The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Economic evaluations of adjunctive osimertinib treatment in surgically resected epidermal growth factor receptor-positive (EGFR+) non-small cell lung cancer (NSCLC): Analysis for stage 2 disease.
 
Briana M Choi
No Relationships to Disclose
 
Osama Aqel
No Relationships to Disclose
 
Rachel B Abraham
No Relationships to Disclose
 
Mavis Obeng-Kusi
No Relationships to Disclose
 
Matthias Calamia
No Relationships to Disclose
 
Hala Halawah
Employment - Farouq and Maamoun Tamer company (I)
 
Ahmad Alamer
No Relationships to Disclose
 
Ali McBride
Employment - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - EMD Serono; Pfizer; Sandoz
Speakers' Bureau - Bristol-Myers Squibb; Coherus Biosciences; Incyte
 
Ivo Abraham
Employment - Matrix45; Matrix45 (I)
Leadership - Matrix45 (I)
Stock and Other Ownership Interests - Matrix45; Matrix45 (I)
Consulting or Advisory Role - Matrix45 (I)
Speakers' Bureau - Matrix45
Research Funding - Matrix45; Matrix45 (I)
Patents, Royalties, Other Intellectual Property - Book royalties
(OPTIONAL) Uncompensated Relationships - Matrix45
 
Deniz Tugay
No Relationships to Disclose